CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 36 filers reported holding CORREVIO PHARMA CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000 | -97.6% | 3,901 | -96.1% | 0.00% | – |
| Q4 2019 | $41,000 | -52.9% | 99,852 | +129.8% | 0.00% | – |
| Q3 2019 | $87,000 | +295.5% | 43,457 | +351.2% | 0.00% | – |
| Q2 2019 | $22,000 | -46.3% | 9,632 | -27.4% | 0.00% | – |
| Q1 2019 | $41,000 | +24.2% | 13,260 | +0.8% | 0.00% | – |
| Q4 2018 | $33,000 | -67.3% | 13,157 | -47.3% | 0.00% | – |
| Q3 2018 | $101,000 | +23.2% | 24,980 | +13.4% | 0.00% | – |
| Q2 2018 | $82,000 | – | 22,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|